SCHEMBL716827

SCHEMBL716827

[CH2]CCCCCNC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.44
MAPK1 P28482 1/20 0.44
HIF1A Q16665 1/20 0.44
PRMT1 Q99873 1/20 0.43
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
ADRA1A P35348 1/20 0.40
EPHX1 P07099 5/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A2 O94788 1/20 0.39
ALDH2 P05091 1/20 0.39
ALDH1A3 P47895 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.38
ZDHHC2 Q9UIJ5 1/20 0.38
PAOX Q6QHF9 2/20 0.37
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28794531 1.00 KDM4E (0.44) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL2865720 1.00 KDM4E (0.44) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL2863141 1.00 KDM4E (0.44) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL28945606 1.00 KDM4E (0.44) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL2864654 0.97
SCHEMBL7463711 0.90
Ethylene SCHEMBL10456946 0.87 KDM4E (0.50) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL15871737 0.87 KDM4E (0.55) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL20836564 0.87 KDM4E (0.55) KDM4EMAPK1HIF1APRMT1ALDH1A1
SCHEMBL5569558 0.87 KDM4E (0.55) KDM4EMAPK1HIF1APRMT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use SHISEIDO COMPANY LTD. (JP) 2007-09-27 US claimed
EP-1688126-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY LIMITED (JP) 2006-08-09 EP claimed
WO-2023068090-A1 AGENT FOR IMPROVING SAGGING PORES 株式会社 資生堂 2023-04-27 WO disclosed
US-9533195-B2 Golf ball DUNLOP SPORTS CO. LTD. (JP) 2017-01-03 US disclosed
US-20160144241-A1 GOLF BALL DUNLOP SPORTS CO. LTD. (JP) 2016-05-26 US disclosed
US-9283439-B2 Golf ball DUNLOP SPORTS CO., LTD. (JP) 2016-03-15 US disclosed
US-20140206476-A1 GOLF BALL DUNLOP SPORTS CO. LTD. (JP) 2014-07-24 US disclosed
US-8586638-B2 Parakeratosis inhibitor and skin preparation for external use SHISEIDO COMPANY, LTD (JP) 2013-11-19 US disclosed
US-8586638-B2 Parakeratosis inhibitor and skin preparation for external use SHISEIDO COMPANY, LTD (JP) 2013-11-19 US disclosed
US-20120253064-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE SHISEIDO COMPANY, LTD. (JP) 2012-10-04 US disclosed
EP-2491981-A2 Parakeratosis inhibitor and external composition for skin SHISEIDO COMPANY LIMITED (JP) 2012-08-29 EP disclosed
CN-1886114-B Parakeratosis inhibitor and composition for external use on skin SHISEIDO CO LTD 2011-08-10 CN disclosed
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use SHISEIDO COMPANY LTD. (JP) 2007-09-27 US disclosed
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use SHISEIDO COMPANY LTD. (JP) 2007-09-27 US disclosed
CN-1886114-A Parakeratosis inhibitor and composition for external use on skin SHISEIDO CO LTD (JP) 2006-12-27 CN disclosed
EP-1688126-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY LIMITED (JP) 2006-08-09 EP disclosed
EP-1688126-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY LIMITED (JP) 2006-08-09 EP disclosed
JP-2005179342-A PARAKERATOSIS-SUPPRESSING AGENT AND PORE SHRINKING AGENT SHISEIDO CO LTD 2005-07-07 JP disclosed
WO-2005051340-A1 PARAKERATOSIS INHIBITOR AND EXTERNAL COMPOSITION FOR SKIN SHISEIDO COMPANY, LTD. (JP) 2005-06-09 WO disclosed
US-4976679-A CATALYTIC REACTION OF PRIMARY AMINE, HYDROXYL COMPOUND, CARBON MONOXIDE, AND OXYGEN MITSUBISHI GAS CHEMICAL COMPANY, INC., A CORP. OF JAPAN (JP) 1990-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120253064-A1 PARAKERATOSIS INHIBITOR AND SKIN PREPARATION FOR EXTERNAL USE CUTA, HPN, PRSS1 KDM4E 1142/4885MAPK1 2138/4885HIF1A 1477/4885
US-20070225380-A1 Parakeratosis Inhibitor and Skin Preparation for External use CUTA, HPN, DNPEP KDM4E 644/4885MAPK1 2285/4885HIF1A 819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.